Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
37.42 USD | +1.14% | -0.93% | -5.65% |
04-17 | Sector Update: Health Care Stocks Mixed Wednesday Afternoon | MT |
04-17 | Celldex Therapeutics Says Patient Enrollment Completed in Chronic Inducible Urticaria Treatment Study; Shares Rise | MT |
Sales 2024 * | 3.39M 4.66M | Sales 2025 * | 3.13M 4.31M | Capitalization | 2.47B 3.4B |
---|---|---|---|---|---|
Net income 2024 * | -170M -234M | Net income 2025 * | -203M -280M | EV / Sales 2024 * | 644 x |
Net cash position 2024 * | 285M 393M | Net cash position 2025 * | 372M 513M | EV / Sales 2025 * | 669 x |
P/E ratio 2024 * |
-12.9
x | P/E ratio 2025 * |
-11.5
x | Employees | 160 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 99.66% |
Latest transcript on Celldex Therapeutics, Inc.
1 day | +1.14% | ||
1 week | -0.93% | ||
1 month | -10.84% | ||
3 months | +6.25% | ||
6 months | +59.10% | ||
Current year | -5.65% |
Managers | Title | Age | Since |
---|---|---|---|
Tibor Keler
FOU | Founder | 65 | 82-12-31 |
Anthony Marucci
FOU | Founder | 62 | 82-12-31 |
Sam Martin
DFI | Director of Finance/CFO | 53 | 09-03-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Herbert Conrad
BRD | Director/Board Member | 91 | 08-02-29 |
Cheryl L. Cohen
BRD | Director/Board Member | 58 | 22-06-15 |
Harry H. Penner
BRD | Director/Board Member | 78 | 96-12-31 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.08% | 2 M€ | -.--% | ||
0.02% | 9 M€ | +4.89% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-04-30 | 37.42 | +1.14% | 526,446 |
24-04-29 | 37 | +1.93% | 499,042 |
24-04-26 | 36.3 | +0.11% | 324,978 |
24-04-25 | 36.26 | -2.05% | 1,021,746 |
24-04-24 | 37.02 | -1.99% | 394,653 |
Delayed Quote Nasdaq, April 30, 2024 at 04:00 pm
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-5.65% | 2.47B | |
+0.17% | 42.19B | |
+10.92% | 42.24B | |
+44.30% | 40.15B | |
-6.20% | 28.31B | |
+5.23% | 24.63B | |
-24.79% | 18.2B | |
+26.69% | 12.01B | |
-3.13% | 11.76B | |
+6.57% | 10.4B |
- Stock Market
- Equities
- CLDX Stock